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ABSTRACT
OBJECTIVE: To analyze the clinical and laboratory characteristics of 
HIV-infected individuals upon admission to a reference health care center. 
METHODS:  This cross-sectional study was conducted between 
1999 and 2010 on 527 individuals with confirmed serological diagnosis of HIV 
infection who were enrolled in an outpatient health care service in Santarém, 
PA, Northern Brazil. Data were collected from medical records and included 
the reason for HIV testing, clinical status, and count of peripheral CD4+ 
T lymphocytes upon enrollment. The data were divided into three groups, 
according to the patient’s year of admission – P1 (1999-2002), P2 (2003-2006), 
and P3 (2007-2010) – for comparative analysis of the variables of interest. 
RESULTS: In the study group, 62.0% of the patients were assigned to the 
P3 group. The reason for undergoing HIV testing differed between genders. 
In the male population, most tests were conducted because of the presence 
of symptoms suggesting infection. Among women, tests were the result of 
knowledge of the partner’s seropositive status in groups P1 and P2. Higher 
proportion of women undergoing testing because of symptoms of HIV/AIDS 
infection abolished the difference between genders in the most recent period. 
A higher percentage of patients enrolling at a more advanced stage of the 
disease was observed in P3. 
CONCLUSIONS: Despite the increased awareness of the number of 
HIV/AIDS cases, these patients have identified their serological status late 
and were admitted to health care units with active disease. The HIV/AIDS 
epidemic in Pará presents specificities in its progression that indicate the 
complex characteristics of the epidemic in the Northern region of Brazil 
and across the country.
DESCRIPTORS: Acquired Immunodeficiency Syndrome, epidemiology. 
HIV Infections, epidemiology. AIDS Serodiagnosis, trends. 
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The Brazilian AIDS epidemic has developed as a mosaic 
of different regional epidemics for four decades.3 The 
detection rate of HIV/AIDS is gradually increasing 
in the Northern region, in contrast to the Southeast 
region, where the rate is gradually decreasing.a This 
increased detection rate is observed in cities with 
more than 500,000 inhabitants, including Belém, in 
the state of Pará, where disease incidence increased 
from 14.3 to 53.5 cases/100,000 inhabitants between 
1997 and 2009.a A similar trend has been observed in 
towns with fewer than 50,000 inhabitants, where the inci-
dence increased from 1.3 to 6.0 cases/100,000 inhabitants 
between 1997 and 2007.b The spread of HIV/AIDS 
infection in Northern Brazil is a recently identi-
fied public health problem. This spread is a cause 
for concern and a challenge because of social, 
RESUMO
OBJETIVO: Analisar as características clínicas e laboratoriais de indivíduos 
infectados pelo HIV na admissão em serviço de referência em saúde.
MÉTODOS: Estudo transversal realizado entre 1999 e 2010, com 527 indivíduos 
com diagnóstico sorológico confirmado de infecção pelo HIV, matriculados 
em serviço de saúde ambulatorial, em Santarém, PA, Brasil. Foram coletadas 
informações de prontuários referentes à população estudada sobre o motivo 
de realização da testagem anti-HIV, estadio clínico e número de linfócitos 
T CD4+ periféricos, no ato da matrícula. Os dados foram distribuídos em três 
grupos, segundo ano de admissão do paciente: 1999 a 2002 (P1), 2003 a 2006 (P2) 
e 2007 a 2010 (P3), para a análise comparativa das variáveis de interesse.
RESULTADOS: Do total estudado, 62,0% dos pacientes foram admitidos 
no grupo P3. O motivo de realização da testagem anti-HIV diferiu entre os 
sexos. Houve preponderância da realização do teste por presença de sintomas 
sugestivos da infecção na população masculina e pelo conhecimento da 
soropositividade do parceiro entre as mulheres nos grupos P1 e P2. A maior 
proporção de mulheres testadas por apresentarem sintomas de infecção pelo 
HIV/aids fez desaparecer essa diferença entre os gêneros no período mais 
recente. Observou-se maior participação de matriculados em fase mais avançada 
da doença no grupo P3.
CONCLUSÕES: Apesar do maior reconhecimento de casos de HIV/aids, os 
pacientes seguem descobrindo seu status sorológico tardiamente e apresentando-se 
à admissão no serviço de saúde com doença em atividade. A epidemia de 
HIV/aids no Pará apresenta especificidades em evolução que compõem o 
complexo mosaico da epidemia na região Norte e no Brasil.
DESCRITORES: Síndrome de Imunodeficiência Adquirida, 
epidemiologia. Infecções por HIV, epidemiologia. Sorodiagnóstico da 
AIDS, tendências.
INTRODUCTION
environmental, cultural, and economic factors that char-
acterize this region and make the population particularly 
vulnerable on individual, social, and program levels.12
Various changes in the socioeconomic scenario have 
been observed in the region in recent decades. The 
opening of new agricultural frontiers for soybean 
production, extensive livestock raising, and the growth 
of the timber industry caused environmental changes 
and a significant migration flow to western Pará.7,19 
Highway BR-163 connects the city of Santarém to 
Cuiabá. In addition, the Tapajós and Amazon Rivers are 
important routes between Santarém, the cities located in 
Western Pará, and other cities in Northern Brazil. These 
routes are used for the circulation of goods and people 
a Boletim Epidemiológico AIDS/DST. Brasília (DF): Ministério da Saúde; 2013;2(1).
b Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais. Brasília (DF); [s.d.].
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and contribute to the spread of infectious diseases 
within the Brazilian Amazon region.1
The influence of these factors in the spread of 
HIV/AIDS should be considered. The constant assess-
ment of specialized health care centers that assist indi-
viduals living with HIV/AIDS may be useful for the 
planning of health care strategies. The identification of 
the reasons that have led users of the Brazilian Unified 
Health System (SUS) in the Santarém region to undergo 
HIV testing and identify the infection stage can help 
identify vulnerabilities and clinical status due to HIV 
infection in the region.
The present study aimed to analyze the clinical and 
laboratory characteristics of HIV-infected individuals 
upon admission to a reference health care center.
METHODS
This cross-sectional study evaluated individuals with 
serologically confirmed diagnosis of HIV infection who 
were enrolled in an outpatient medical service at the 
Centro de Testagem e Aconselhamento (CTA – Testing 
and Counseling Center) in Santarém between January 
1999 and December 2010. This period corresponded 
to the date of patient admission to the health care unit 
where the study was conducted.
Specialized health care to individuals living with 
HIV/AIDS began in Western Pará in 1998 with the 
implementation of a CTA nine years after the first 
official report of an AIDS case in the municipality 
of Santarém. This initiative started 10 years after the 
establishment of the first CTA in Southeastern Brazil.c 
Santarém’s CTA offers testing and counseling services 
and, since its creation, has become a reference center 
for outpatient monitoring and treatment of individuals 
living with HIV/AIDS in the cities located in the Lower 
Amazon and Southwest Pará regions, which have an 
area of 722,358 km2 and approximately one million 
inhabitants.d This unit offers several multidisciplinary 
services including pharmaceutical and psychological 
care and involves physicians and nurses.
Outpatient consultations, dispensing of antiretro-
viral drugs, sample collection for laboratory testing, 
epidemiological surveillance of HIV/AIDS infection, 
and application of immunobiological agents have 
been offered at the Santarém CTA since 1999. This 
CTA became a Serviço de Assistência Especializada 
(SAE – Specialized Assistance Service) according to 
the guidelines proposed by the Brazilian Ministry of 
Health in 2008.e
This study included individuals with a serologically 
confirmed diagnosis of HIV infection, according to the 
criteria established by the Ministry of Health.f Patients 
transferred from other units, and those under 13 years 
infected with HIV were excluded.
The data were extracted from the medical records of 
the health care unit, which has a standardized form for 
recording information collected upon patient admission. 
Data on the patient status upon admission to the health 
care unit were systematically collected up to 90 days 
after enrollment.
The variables of interest in the study were as follows: 
reason for undergoing serological HIV testing, clinical 
stage of HIV infection according to the criteria estab-
lished by the Centers for Disease Control in 2008,5 
count of peripheral CD4+ T lymphocytes, and period in 
which the subjects enrolled in the Santarém CTA/SAE.
The variable “reason for HIV testing” was classified on 
the basis of the participants’ statement recorded in the 
medical history using the following mutually exclusive 
categories: presence of signs and symptoms suggestive 
of HIV/AIDS, asymptomatic patient with seropositive 
partner, occurrence of sexually transmitted disease, 
prenatal serological screening, perceived risk based 
on reports of suspected exposure to HIV, serological 
screening at a blood bank, child’s serological diagnosis, 
or information not provided.
The variable “period enrolled in the service” was clas-
sified into three periods: 1999-2002, 2003-2006, and 
2007-2010, and comprised groups P1, P2, and P3, 
respectively. These periods were operationally defined 
considering the programmatic changes in the health care 
units provided to individuals living with HIV/AIDS in 
the region. In this respect, the center at Santarém was 
restructured and became a reference center for the 
25 municipalities during P1; novel diagnostic routines 
were implemented, including a rapid serological 
testing; two CTA were opened in neighboring munici-
palities containing the largest population in the region 
(Oriximiná and Itaituba) during P2 and in four other 
municipalities in Western Pará during P3.
The frequency of the variables “reason for HIV testing” 
and “clinical and laboratory status upon admission” and 
c Ministério da Saúde. Programa Nacional DST e AIDS. Contribuição dos centros de testagens e aconselhamento para universalizar o 
diagnóstico e garantir a equidade no acesso aos serviços. Brasília (DF); 2008. 
d Instituto Brasileiro de Geografia e Estatística. Censo demográfico 2010. Brasília (DF); 2010 [cited 2014 Feb 15]. Available from: http://www.
censo2010.ibge.gov.br/
e Ministério da Saúde. Departamento Nacional DST/AIDS. Serviço de assistência especializada em HIV/Aids. Brasília (DF);[s.d.] [cited 2014 
Feb 15]. Available from: http://www.aids.gov.br/tipo_endereco/servico-de-assistencia-especializada-em-hivaids
f Ministério da Saúde. Programa Nacional DST e AIDS. Recomendações para terapia antirretroviral em adultos infectados pelo HIV. Brasília 
(DF); 2008. 
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the peripheral CD4+ lymphocyte count (dependent vari-
ables) were compared during P1, P2 and P3 (indepen-
dent variables). The variable “reason for undergoing 
HIV testing” also was compared between the genders.
The variables were distributed using the Kolmogorov-
Smirnov test. The Chi-square test was used to investi-
gate the association between the reason for HIV testing 
and patient gender, and between the clinical stage of 
HIV and the enrollment period in the CTA in each of 
the periods studied. In cases where the Chi-square test 
results indicated differences between the groups, the 
association between the clinical stage and each evalu-
ation period was investigated in the period 1999-2001. 
Logistic regression used odds ratios (OR) and their 
respective 95% confidence intervals. The CD4+ T 
lymphocyte counts were compared between each period 
evaluated using the Kruskal-Wallis test. A statistical 
significance level of 5% was adopted for all analyses.
The EpiData version 2.1 software was used to prepare 
the data and SPSS software version 15.0 was used for 
statistical analysis.
The study was approved by the Ethics Committee 
for Review of Research Projects (CAPPesq) at the 
Hospital das Clínicas of the Faculdade de Medicina 
of the Universidade de São Paulo. Obtaining terms 
of informed consent was not necessary because 
the study was based on review of medical records. 
Subject anonymity and information confidentiality 
were ensured.
RESULTS
Between 1999 and 2010, 613 patients considered 
eligible for the study were enrolled in the Santarém 
CTA/SAE. Of these, 23 patients aged < 13 years at 
admission and 63 individuals who were transferred to 
other health care units were excluded, leaving a total 
of 527 subjects.
The distribution of the participants according to the 
period of admission in the health care unit was as 
follows: 71 patients were assigned to P1 (1999-2002), 
127 were assigned to P2 (2003-2006), and 329 were 
assigned to P3 (2007-2010).
The reason for undergoing HIV testing (Table 1) 
differed significantly between the genders (p < 0.002). 
Although 57.6% of men and 48.3% of women under-
went testing because of the presence of signs and 
symptoms suggestive of HIV/AIDS infection, 34.2% 
of women and 18.1% of men were tested because they 
had a partner who was seropositive for HIV. Testing 
during prenatal care was excluded from the compara-
tive analysis between the genders because it exclusively 
applied to women. However, 30.5% of women discov-
ered their seropositive status during prenatal care. This 
was the second most frequent reason for testing among 
women, surpassed only by the presence of signs sugges-
tive of HIV/AIDS infection (33.3%).
Comparative analysis of the reason for undergoing HIV 
testing according to gender and period of enrollment in 
the service is presented in Table 2. The category “other 
reasons for testing” was taken as a reference for calcu-
lation, aggregating all the categories for this variable 
except “signs and symptoms suggestive of HIV/AIDS” 
and “prenatal screening”, which were intentionally 
excluded. A statistically significant difference was 
observed in P1 and P2; among men belonging to P1, this 
difference was observed in the predominance of tests 
conducted due to the presence of signs and symptoms 
suggestive of HIV infection. Meanwhile, women were 
tested because of “other reasons for testing” in 83.3% 
and 55.6% of the cases in P1 and P2, respectively. 
The reasons for HIV testing were similar between the 
Table 1. Distribution of individuals living with HIV/AIDS by gender and reason for HIV testing upon admission to CTA/SAE. 
Santarém, PA, Northern Brazil, 1999-2010.
 Reason for HIV testinga 
Gender
Total p
 
 
Male Female
   
n % n % n %
Signs and symptoms of HIV/AIDS infection 178 57.6 72 48.3 250 54.6 0.002b
Asymptomatic with seropositive partner 56 18.1 51 34.2 107 23.4  
Perceived risk 41 13.3 13 8.7 54 11.8  
Other reasonsc 34 11.0 13 8.7 47 10.3  
CTA/SAE: Testing and Counseling Center/Specialized Assistance Service
a The “prenatal screening” category was excluded from the analysis because it applied exclusively to women.
b Chi-square test.
c Occurrence of sexually transmitted disease; HIV seropositive status identified at a blood bank; child’s serological diagnosis.
Data were absent for three patients.
Values  with statistical significance are shown in bold.
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genders in P3. However, the categories for this variable 
showed inverse order, so that women in P3 were tested 
because of the presence of signs and symptoms sugges-
tive of HIV/AIDS infection in 55.8% of the cases.
When considering the entire study period, 52.0% of 
the individuals were classified as stage III at the time 
of admission to the unit as per CDC guideline, charac-
terized by count of < 200 peripheral CD4+ T lympho-
cytes/mm3 and/or the presence of at least one AIDS-
defining disease.f CD4+ T lymphocytes were counted 
in the peripheral blood in 390 patients, with a median 
count of 306 cells/mm3 (range between 3 and 1,665).
Table 3 shows the frequency distribution of each 
clinical stage according to the CDC classification of 
2008 in the three periods studied. Differences in the 
clinical stages were observed in each period, with a 
decrease of stage 1 and increase of stages 2 and 3 in 
P3, between 1999 and 2002 (Table 4).
The median number of peripheral CD4+ T cells at the 
time of admission to the unit in P1, P2, and P3 was 
461, 357, and 261 cells/mm3, respectively. There was a 
significant difference between each period (p < 0.001) 
(Figure 1): the medians in P1 were higher than those in 
P3 (p < 0.001), and the median in P2 was higher than 
that in P3 (p = 0.0037).
DISCUSSION
The increase in the number of individuals enrolled 
in the Santarém CTA/SAE in the study period 
confirms national epidemiological data related to the 
growth of the epidemic in the Northern region.15,17 
Grangeiro et al10 (2011) stated that programmatic inter-
ventions such as the opening of CTA, development of 
Table 2. Distribution of individuals living with HIV/AIDS enrolled in CTA/SAE, according to the reason for HIV testing, gender, 
and registration period. Santarém, PA, Northern Brazil, 1999-2010.
Registration 
period
Reason for HIV testinga 
Gender
Total
pc
 
Male Female
   
n % n % n
P1 Signs and symptoms suggesting HIV/AIDS infection 29 61.7 3 16.7 32 0.003
Other reasons for testing b 18 38.3 15 83.3 33
P2 Signs and symptoms suggesting HIV/AIDS infection 48 64.9 16 44.4 64 0.044
Other reasons for testing b 26 35.1 20 55.6 46
P3 Signs and symptoms suggesting HIV/AIDS infection 101 53.7 53 55.8 154 0.742
Other reasons for testing b 87 46.3 42 44.2 129
CTA/SAE: Testing and Counseling Center/Specialized Assistance Service. P1: 1999-2002
P2: 2003-2006
P3: 2007-2010
a The “prenatal screening” category was excluded from the analysis because it applied exclusively to women.
b Other reasons for testing: asymptomatic seropositive partner; perceived risk; other reasons.
c Chi-square test.
Data were absent for three patients.
Values  with statistical significance are shown in bold.
Table 3. Distribution of individuals living with HIV/AIDS enrolled in CTA/SAE, according to the clinical stage of HIV infection 
and enrollment period. Santarém, PA, Northern Brazil, 1999-2010.
Clinical stage of HIV
Enrollment period
Total
p*
 
P1 P2 P3
    
n % n % n % n %
Stage 1 24 36.4 33 28.7 65 21.2 122 25.1 0.008
Stage 2 13 19.7 16 13.9 83 27.1 112 23.0  
Stage 3 29 43.9 66 57.4 158 51.6 253 52.0  
CTA/SAE: Testing and Counseling Center/Specialized Assistance Service
P1: 1999-2002
P2: 2003-2006
P3: 2007-2010
* Result of Chi-square test.
Values  with statistical significance are shown in bold.
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the rapid HIV test, and changes in program manage-
ment involving the decentralization of health care 
activities contributed to the increased reporting of 
cases in Northern Brazil. The mean incidence of AIDS 
was 25 cases/100,000 inhabitants in cities with CTA, 
compared with 17.5 cases/100,000 in other cities.8 Of 
the 25 municipalities in the region in which Santarém 
is a reference health care center for people living with 
HIV/AIDS, seven had CTA within their borders by 
2011, four of which opened between 2007 and 2010.
Few studies have assessed the reasons that have led 
SUS users to undergo serological testing for HIV.2,9 
The acknowledgment of an individual’s serological 
status has a direct impact on prognosis and on the 
sexual partners’ vulnerability to virus acquisition. 
This study showed that the most frequent reason for 
testing among men and women in health care units in 
Santarém was the presentation of signs and symptoms 
suggestive of HIV/AIDS infection. Other reasons for 
testing that could lead to earlier access to diagnosis were 
also investigated and were described independently 
for both genders. The increased frequency of testing 
in asymptomatic women with a seropositive partner 
indicates gender inequalities in the study population 
and reveals conditions of greater vulnerability among 
the women assisted in these units. Gender differences 
associated with the reasons for HIV testing were also 
found in a cohort of patients monitored in Sao Paulo, 
SP, Southeastern Brazil. Braga et al2 (2007) analyzed 
1,229 patients between 1998 and 2002 and noted that 
43.0% of men underwent testing because of the pres-
ence of signs and symptoms of HIV/AIDS whereas 
36.0% of women were tested because they had an 
HIV-positive partner. Gender inequalities in health care 
services in regions with distinct social and program-
matic characteristics, such as Sao Paulo and Amazonia, 
suggest that women’s vulnerability to HIV is associ-
ated with the way they relate to their partners, their 
role in society, and how programmatic responses are 
prepared to confront the issues that affect their health.12 
Pascom et al13 (2011) investigated sexual behavior in 
a sample of 8,000 men and women in all regions of 
Brazil and observed a lower frequency of sexual activity 
among women, fewer casual partners, and less frequent 
condom use compared with men.
Table 4. Comparative analysis between the periods of enrollment and the clinical stage in individuals living with HIV/AIDS 
enrolled in CTA/SAE. Santarém, PA, Northern Brazil, 1999-2010.
Registration period Clinical stage OR 95%CI p*
P2 1 1   
2 0.90 0.36;2.20 0.810
3 1.66 0.84;3.28 0.148
P3 1 1   
2 2.36 1.11;4.99 0.025
3 2.01 1.09;3.71 0.025
CTA/SAE: Testing and Counseling Center/Specialized Assistance Service
P2: 2002-2006
P3: 2007-2010
* Logistic regression.
P2 (1999-2002) was adopted as a reference.
Values  with statistical significance are shown in bold.
CTA/SAE: Testing and Counseling Center/Specialized 
Assistance Service
* Kruskal-Wallis (p < 0.001).
Figure 1. Box plot of the median count of peripheral TCD4+ 
lymphocytes according to enrollment periods of individuals 
living with HIV/AIDS admitted to CTA/SAE. Santarém, PA, 
Northern Brazil, 1999-2010.
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For women in the sexually active age group, prenatal 
serological HIV testing represented an opportunity to 
identify their serological status in the early stages of 
infection. However, prenatal HIV testing is compara-
tively less frequent in the region studied compared with 
other Brazilian regions. The Northern region has the 
worst HIV testing coverage: 55.0% of pregnant women 
do not have access to prenatal HIV testing, according 
to 2006 data.18 This finding is reinforced by studies that 
have found the highest proportional rates of maternal-
fetal HIV transmission in Northern Brazil4,16 and indi-
cates the lower efficiency of prenatal and perinatal care 
for women in this region.
This study allowed the comparison of reasons for HIV 
testing upon admission to the health care unit over a 
12-year period and found gender differences. The iden-
tification of HIV status in women in P1 and P2 was 
dependent on the HIV infection status of their part-
ners, who in turn most often presented with signs and 
symptoms related to HIV/AIDS in the three periods. In 
P3, women identified their HIV status mainly because 
of the presence of signs and symptoms of HIV/AIDS. 
Therefore, HIV/AIDS infection may have been 
present for longer in men compared with women, and 
this would explain why women exhibited the disease 
primarily in P3.
Programmatic interventions have a greater scope in 
Western Pará and were characterized by the decentral-
ization of diagnostic HIV testing and opening of four 
new CTA in P2 and P3, respectively. Nevertheless, more 
than 50.0% of the registered individuals learned their 
HIV status in a late stage in the comparative temporal 
analysis. The increase in HIV testing in the region 
between 1999 and 2010 was not limited to Santarém 
but spread to other locations where CTA were opened. 
Many patients have limited geographical access to 
reference health care units, which would justify the 
diagnosis of infection in more advanced stages of the 
disease. Late diagnosis of infection in the study popula-
tion is consistent with the increased mortality rate due 
to AIDS in Northern Brazil.6,19
These results are similar to those found in other cities 
in the Northern region. Silva et al15 (2009) evaluated 
1,400 patients admitted with HIV/AIDS in Manaus, 
AM, Northern Brazil, between 1986 and 2000; of these, 
50.8% had late diagnosis, with increased frequency 
of subjects admitted at later stages of the disease. 
Approximately 40.0% of HIV-positive individuals were 
admitted to reference health care units located in favela 
communities in Rio de Janeiro, RJ, Southeastern Brazil, 
in late stages.14 At an outpatient clinic in central Sao 
Paulo, 52.0% of seropositive individuals were found to 
have at least one opportunistic AIDS-defining disease 
prior to admission.2 Late diagnosis of HIV/AIDS infec-
tion does not seem to be exclusive to Brazilian services: 
the median CD4+ T lymphocyte count upon admission 
to reference health care units in a multicenter study in 
the United States was between 167 and 175 cells/mm3.11
Clinical data were obtained from medical records, 
which could have limited the internal validity of this 
study. However, the records analyzed had a standard-
ized form for data collection upon patient’ admission. 
Consequently, potential information bias may have 
been minimized. We chose to analyze the clinical stages 
and the median CD4+ T lymphocyte count separately 
because the latter variable exclusively included labo-
ratory data that were ignored for a significant number 
of individuals (137). Although this strategy is standard 
procedure according to Ministry of Health norms, the 
limitations of laboratory infrastructure in the region 
limited the access to the procedure between 1999 and 
2006 (P1 and P2). The assessment of the clinical stage 
by evaluation of the clinical status of the patient upon 
admission allowed more subjects to be included in the 
analysis, considering that the data from 40 patients had 
been ignored. Only patients living with HIV/AIDS who 
had access to the specialized unit in the region were 
evaluated. The clinical and laboratory characteristics 
of these individuals may differ from other subjects who 
did not have access to HIV testing or to the Santarém 
CTA/SAE for various reasons, although they resided 
in the same region.
Programmatic interventions such as the opening of 
CTA, provision of rapid diagnostic testing, decentral-
ization of activities, and transfer of funds to municipali-
ties, may have increased the access to serological diag-
nosis of infection in the period evaluated. Consequently, 
these interventions may have increased the demand 
for care in reference health care units in Western Pará. 
Therefore, future second-generation epidemiological 
surveillance studies should be conducted to assess the 
impact of these interventions and identify the groups 
most vulnerable to HIV infection in the region, in terms 
of viral acquisition of and risk of developing AIDS. This 
could help establish effective strategies for the early 
diagnosis, and these strategies should be implemented 
to improve the quality of life of people living with 
HIV/AIDS, reduce mortality associated with AIDS, 
and reduce the transmission of HIV.
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